287 related articles for article (PubMed ID: 12694613)
1. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development.
Fields KA; Mead DJ; Dooley CA; Hackstadt T
Mol Microbiol; 2003 May; 48(3):671-83. PubMed ID: 12694613
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
Fields KA; Hackstadt T
Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis.
Weber MM; Bauler LD; Lam J; Hackstadt T
Infect Immun; 2015 Dec; 83(12):4710-8. PubMed ID: 26416906
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane.
Olson MG; Ouellette SP; Rucks EA
J Proteomics; 2020 Feb; 212():103595. PubMed ID: 31760040
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA.
Fields KA; Fischer E; Hackstadt T
Infect Immun; 2002 Jul; 70(7):3816-23. PubMed ID: 12065525
[TBL] [Abstract][Full Text] [Related]
7. Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model.
Chellas-Géry B; Linton CN; Fields KA
Cell Microbiol; 2007 Oct; 9(10):2417-30. PubMed ID: 17532760
[TBL] [Abstract][Full Text] [Related]
8. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.
Shaw EI; Dooley CA; Fischer ER; Scidmore MA; Fields KA; Hackstadt T
Mol Microbiol; 2000 Aug; 37(4):913-25. PubMed ID: 10972811
[TBL] [Abstract][Full Text] [Related]
9. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
[TBL] [Abstract][Full Text] [Related]
10. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.
Hower S; Wolf K; Fields KA
Mol Microbiol; 2009 Jun; 72(6):1423-37. PubMed ID: 19460098
[TBL] [Abstract][Full Text] [Related]
11. The Human Centrosomal Protein CCDC146 Binds
Almeida F; Luís MP; Pereira IS; Pais SV; Mota LJ
Front Cell Infect Microbiol; 2018; 8():254. PubMed ID: 30094225
[No Abstract] [Full Text] [Related]
12. Inclusion Membrane Growth and Composition Are Altered by Overexpression of Specific Inclusion Membrane Proteins in Chlamydia trachomatis L2.
Olson-Wood MG; Jorgenson LM; Ouellette SP; Rucks EA
Infect Immun; 2021 Jun; 89(7):e0009421. PubMed ID: 33875478
[TBL] [Abstract][Full Text] [Related]
13. The inclusion membrane protein IncS is critical for initiation of the Chlamydia intracellular developmental cycle.
Cortina ME; Bishop RC; DeVasure BA; Coppens I; Derré I
PLoS Pathog; 2022 Sep; 18(9):e1010818. PubMed ID: 36084160
[TBL] [Abstract][Full Text] [Related]
14. Homologues of the Chlamydia trachomatis and Chlamydia muridarum Inclusion Membrane Protein IncS Are Interchangeable for Early Development but Not for Inclusion Stability in the Late Developmental Cycle.
Cortina ME; Derré I
mSphere; 2023 Apr; 8(2):e0000323. PubMed ID: 36853051
[TBL] [Abstract][Full Text] [Related]
15. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.
Muschiol S; Bailey L; Gylfe A; Sundin C; Hultenby K; Bergström S; Elofsson M; Wolf-Watz H; Normark S; Henriques-Normark B
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14566-71. PubMed ID: 16973741
[TBL] [Abstract][Full Text] [Related]
16. Proximity Labeling To Map Host-Pathogen Interactions at the Membrane of a Bacterium-Containing Vacuole in Chlamydia trachomatis-Infected Human Cells.
Olson MG; Widner RE; Jorgenson LM; Lawrence A; Lagundzin D; Woods NT; Ouellette SP; Rucks EA
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31405957
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.
Saka HA; Thompson JW; Chen YS; Kumar Y; Dubois LG; Moseley MA; Valdivia RH
Mol Microbiol; 2011 Dec; 82(5):1185-203. PubMed ID: 22014092
[TBL] [Abstract][Full Text] [Related]
18. Absence of Specific Chlamydia trachomatis Inclusion Membrane Proteins Triggers Premature Inclusion Membrane Lysis and Host Cell Death.
Weber MM; Lam JL; Dooley CA; Noriea NF; Hansen BT; Hoyt FH; Carmody AB; Sturdevant GL; Hackstadt T
Cell Rep; 2017 May; 19(7):1406-1417. PubMed ID: 28514660
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic SNARE VAMP3 Dynamically Interacts with Multiple Chlamydial Inclusion Membrane Proteins.
Bui DC; Jorgenson LM; Ouellette SP; Rucks EA
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33229367
[No Abstract] [Full Text] [Related]
20. Single-Inclusion Kinetics of
Chiarelli TJ; Grieshaber NA; Omsland A; Remien CH; Grieshaber SS
mSystems; 2020 Oct; 5(5):. PubMed ID: 33051378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
